Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques
ABSTRACTIn the last few decades, Ebola virus (EBOV) has emerged periodically and infected people in Africa, resulting in an extremely high mortality rate. With no available prophylaxis or cure so far, a highly effective Ebola vaccine is urgently needed. In this study, we developed a novel chimpanzee...
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Taylor & Francis Group
2019-01-01
|
| Col·lecció: | Emerging Microbes and Infections |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/22221751.2019.1644968 |